153 related articles for article (PubMed ID: 19422802)
1. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
2. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus.
Tanaka Y; Amano A; Morisaki M; Sato Y; Sasaki T
Antiviral Res; 2016 Feb; 126():1-7. PubMed ID: 26675666
[TBL] [Abstract][Full Text] [Related]
3. Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
Moore JD; Potter A
Bioorg Med Chem Lett; 2013 Aug; 23(15):4283-91. PubMed ID: 23796453
[TBL] [Abstract][Full Text] [Related]
4. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.
Uchida T; Takamiya M; Takahashi M; Miyashita H; Ikeda H; Terada T; Matsuo Y; Shirouzu M; Yokoyama S; Fujimori F; Hunter T
Chem Biol; 2003 Jan; 10(1):15-24. PubMed ID: 12573694
[TBL] [Abstract][Full Text] [Related]
5. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
8. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
9. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
12. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.
Islam R; Yoon H; Shin HR; Bae HS; Kim BS; Yoon WJ; Woo KM; Baek JH; Lee YS; Ryoo HM
J Cell Physiol; 2018 Dec; 233(12):9390-9403. PubMed ID: 30132832
[TBL] [Abstract][Full Text] [Related]
14. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
[TBL] [Abstract][Full Text] [Related]
15. Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase Pin1.
Ohashi T; Teshima S; Hidaka M; Uchida T
Biosci Biotechnol Biochem; 2010; 74(10):2067-70. PubMed ID: 20944414
[TBL] [Abstract][Full Text] [Related]
16. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
18. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
19. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
Velazquez HA; Hamelberg D
J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
[TBL] [Abstract][Full Text] [Related]
20. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
